Overview

Statin Lowering Testosterone and Sexual Function

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Statins may decrease serum testosterone levels via decreasing cholesterol. This longitudinal study detected the effects of rosuvastatin on free testosterone levels and sexual function in men with type 2 diabetes. Methods: Investigator enroll 150 men with type 2 diabetes and hypercholesterolemia. Biochemical assessments include serum total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein, triglyceride, prolactin, thyroid-stimulating hormone, luteinizing hormone, follicle stimulating hormone, total testosterone and serum sex hormone binding globulin (SHBG). All parameters are measured before statin treatment, after 6 months of statin treatment and 6 months after discontinuing statin treatment. Scores of the sexual health inventory for men (SHIM) are also evaluated.
Phase:
Phase 4
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Treatments:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Methyltestosterone
Rosuvastatin Calcium
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate